Prevalence of Extended-Spectrum β-Lactamases in Multidrug-Resistant Klebsiella pneumoniae Isolates in Jordanian Hospitals
The increase in the prevalence of infections caused by certain bacteria, such as Klebsiella pneumonia ( K. pneumoniae ), is a global health concern. Bacterial production of an enzyme called extended-spectrum beta-lactamase (ESBL) can generate resistance to antimicrobial therapeutics. Therefore, betw...
Gespeichert in:
Veröffentlicht in: | Journal of Epidemiology and Global Health 2023-06, Vol.13 (2), p.180-190 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 190 |
---|---|
container_issue | 2 |
container_start_page | 180 |
container_title | Journal of Epidemiology and Global Health |
container_volume | 13 |
creator | Al-Sheboul, Suhaila A. Al-Madi, Ghina S. Brown, Brent Hayajneh, Wail A. |
description | The increase in the prevalence of infections caused by certain bacteria, such as
Klebsiella pneumonia
(
K. pneumoniae
), is a global health concern. Bacterial production of an enzyme called extended-spectrum beta-lactamase (ESBL) can generate resistance to antimicrobial therapeutics. Therefore, between 2012 and 2013, we investigated
K. pneumoniae
that produce ESBLs with the prevalence of individual genes including
bla
SHV
,
bla
CTX-M
,
bla
TEM
, and
bla
OXA
isolated from clinical samples. A total of 99 variable diagnostic samples including blood from hematological malignancies (
n
= 14) or other clinical sources including sputum, pus, urine, and wound (
n
= 85) were analyzed. All samples' bacterial type was confirmed and their susceptibility to antimicrobial agents was established. Polymerase chain reaction (PCR) amplification was carried out to ascertain presence of specific genes that included
bla
SHV
,
bla
CTX-M
,
bla
TEM
, and
bla
OXA.
Plasmid DNA profiles were determined to assess significance between resistance to antimicrobial agents and plasmid number. It was found that among non-hematologic malignancy isolates, the highest rate of resistance was 87.9% to imipenem, with lowest rate being 2% to ampicillin. However, in hematologic malignancy isolates, the highest microbial resistance was 92.9% to ampicillin with the lowest rate of resistance at 28.6% to imipenem. Among collected isolates, 45% were ESBL-producers with 50% occurrence in hematologic malignancy individuals that were ESBL-producers. Within ESBL-producing isolates from hematologic malignancy individuals
, bla
SHV
was detected in 100%,
bla
CTX
-M
in 85.7%, and
bla
TEM
and
bla
OXA-1
at 57.1% and 27.1%, respectively. In addition,
bla
SHV,
bla
CTX-M
, and
bla
OXA
were found in all non-hematological malignancy individuals with
bla
TEM
detected in 55.5% of samples. Our findings indicate that ESBLs expressing
bla
SHV
and
bla
CTX-M
genes are significantly prevalent in
K. pneumoniae
isolates from hematologic malignancy individuals. Plasmid analysis indicated plasmids in isolates collected from hematological malignancy individuals. Furthermore, there was a correlation between resistance to antimicrobial agents and plasmids within two groups analyzed. This study indicates an increase in incidence of
K. pneumoniae
infections displaying ESBL phenotypes in Jordan. |
doi_str_mv | 10.1007/s44197-023-00096-2 |
format | Article |
fullrecord | <record><control><sourceid>pubmed_doaj_</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10272028</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_86cb5380cf374d95b46c2e8c44ae9977</doaj_id><sourcerecordid>37095370</sourcerecordid><originalsourceid>FETCH-LOGICAL-c513t-c5c9d41de4cb7fd00650a359fb79d7282052da7e25f9c2558d544a4f6c9bc92d3</originalsourceid><addsrcrecordid>eNp9kU9u1TAQxiMEolXpBVigXCAwduw4XiFUlfbBQyD-rC3HnjxcJXZkOxVwLA7CmTANVO2GzcxoZr7fSPNV1VMCzwmAeJEYI1I0QNsGAGTX0AfVMaUEmg4Ie3inPqpOU3IDMCYlZ9A-ro5aAZKXcFz9-BDxWk_oDdZhrM-_ZfQWbfNpQZPjOte_fjZ7bbKedcJUO1-_W6fsbFwPzUdMLmXtc_12wiE5nCZdLx7XOXinsd6lMOm8qd6EaHXp-voypMVlPaUn1aOxJDz9m0-qL6_PP59dNvv3F7uzV_vGcNLmEo20jFhkZhCjBeg46JbLcRDSCtpT4NRqgZSP0lDOe8sZ02zsjByMpLY9qXYb1wZ9pZboZh2_q6CdummEeFA6ZmcmVH1nBt72YMZWMCv5wDpDsTcFiFIKUVgvN9ayDjNagz5HPd2D3p9491UdwrUiQAUF2hcC3QgmhpQijrdiAuqPs2pzVhVn1Y2zihbRs7tnbyX_fCwL7baQysgfMKqrsEZf3vo_7G_N2LKq</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Prevalence of Extended-Spectrum β-Lactamases in Multidrug-Resistant Klebsiella pneumoniae Isolates in Jordanian Hospitals</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central Open Access</source><source>Springer Nature OA Free Journals</source><source>PubMed Central</source><source>SpringerLink Journals - AutoHoldings</source><creator>Al-Sheboul, Suhaila A. ; Al-Madi, Ghina S. ; Brown, Brent ; Hayajneh, Wail A.</creator><creatorcontrib>Al-Sheboul, Suhaila A. ; Al-Madi, Ghina S. ; Brown, Brent ; Hayajneh, Wail A.</creatorcontrib><description>The increase in the prevalence of infections caused by certain bacteria, such as
Klebsiella pneumonia
(
K. pneumoniae
), is a global health concern. Bacterial production of an enzyme called extended-spectrum beta-lactamase (ESBL) can generate resistance to antimicrobial therapeutics. Therefore, between 2012 and 2013, we investigated
K. pneumoniae
that produce ESBLs with the prevalence of individual genes including
bla
SHV
,
bla
CTX-M
,
bla
TEM
, and
bla
OXA
isolated from clinical samples. A total of 99 variable diagnostic samples including blood from hematological malignancies (
n
= 14) or other clinical sources including sputum, pus, urine, and wound (
n
= 85) were analyzed. All samples' bacterial type was confirmed and their susceptibility to antimicrobial agents was established. Polymerase chain reaction (PCR) amplification was carried out to ascertain presence of specific genes that included
bla
SHV
,
bla
CTX-M
,
bla
TEM
, and
bla
OXA.
Plasmid DNA profiles were determined to assess significance between resistance to antimicrobial agents and plasmid number. It was found that among non-hematologic malignancy isolates, the highest rate of resistance was 87.9% to imipenem, with lowest rate being 2% to ampicillin. However, in hematologic malignancy isolates, the highest microbial resistance was 92.9% to ampicillin with the lowest rate of resistance at 28.6% to imipenem. Among collected isolates, 45% were ESBL-producers with 50% occurrence in hematologic malignancy individuals that were ESBL-producers. Within ESBL-producing isolates from hematologic malignancy individuals
, bla
SHV
was detected in 100%,
bla
CTX
-M
in 85.7%, and
bla
TEM
and
bla
OXA-1
at 57.1% and 27.1%, respectively. In addition,
bla
SHV,
bla
CTX-M
, and
bla
OXA
were found in all non-hematological malignancy individuals with
bla
TEM
detected in 55.5% of samples. Our findings indicate that ESBLs expressing
bla
SHV
and
bla
CTX-M
genes are significantly prevalent in
K. pneumoniae
isolates from hematologic malignancy individuals. Plasmid analysis indicated plasmids in isolates collected from hematological malignancy individuals. Furthermore, there was a correlation between resistance to antimicrobial agents and plasmids within two groups analyzed. This study indicates an increase in incidence of
K. pneumoniae
infections displaying ESBL phenotypes in Jordan.</description><identifier>ISSN: 2210-6014</identifier><identifier>ISSN: 2210-6006</identifier><identifier>EISSN: 2210-6014</identifier><identifier>DOI: 10.1007/s44197-023-00096-2</identifier><identifier>PMID: 37095370</identifier><language>eng</language><publisher>Dordrecht: Springer Netherlands</publisher><subject>Ampicillin ; Anti-Bacterial Agents - pharmacology ; Anti-Bacterial Agents - therapeutic use ; beta-Lactamases - genetics ; Extended-spectrum β-lactamases ; Hematological malignancy ; Hospitals ; Humans ; Imipenem ; Jordan ; Jordan - epidemiology ; Klebsiella pneumoniae ; Klebsiella pneumoniae - genetics ; Medicine ; Medicine & Public Health ; Multidrug resistance ; Plasmid profile ; Prevalence ; Research Article</subject><ispartof>Journal of Epidemiology and Global Health, 2023-06, Vol.13 (2), p.180-190</ispartof><rights>The Author(s) 2023. corrected publication 2023</rights><rights>2023. The Author(s).</rights><rights>The Author(s) 2023, corrected publication 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c513t-c5c9d41de4cb7fd00650a359fb79d7282052da7e25f9c2558d544a4f6c9bc92d3</citedby><cites>FETCH-LOGICAL-c513t-c5c9d41de4cb7fd00650a359fb79d7282052da7e25f9c2558d544a4f6c9bc92d3</cites><orcidid>0000-0001-5238-6943 ; 0000-0001-9001-3232 ; 0000-0003-1816-9018</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10272028/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10272028/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,27923,27924,53790,53792</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37095370$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Al-Sheboul, Suhaila A.</creatorcontrib><creatorcontrib>Al-Madi, Ghina S.</creatorcontrib><creatorcontrib>Brown, Brent</creatorcontrib><creatorcontrib>Hayajneh, Wail A.</creatorcontrib><title>Prevalence of Extended-Spectrum β-Lactamases in Multidrug-Resistant Klebsiella pneumoniae Isolates in Jordanian Hospitals</title><title>Journal of Epidemiology and Global Health</title><addtitle>J Epidemiol Glob Health</addtitle><addtitle>J Epidemiol Glob Health</addtitle><description>The increase in the prevalence of infections caused by certain bacteria, such as
Klebsiella pneumonia
(
K. pneumoniae
), is a global health concern. Bacterial production of an enzyme called extended-spectrum beta-lactamase (ESBL) can generate resistance to antimicrobial therapeutics. Therefore, between 2012 and 2013, we investigated
K. pneumoniae
that produce ESBLs with the prevalence of individual genes including
bla
SHV
,
bla
CTX-M
,
bla
TEM
, and
bla
OXA
isolated from clinical samples. A total of 99 variable diagnostic samples including blood from hematological malignancies (
n
= 14) or other clinical sources including sputum, pus, urine, and wound (
n
= 85) were analyzed. All samples' bacterial type was confirmed and their susceptibility to antimicrobial agents was established. Polymerase chain reaction (PCR) amplification was carried out to ascertain presence of specific genes that included
bla
SHV
,
bla
CTX-M
,
bla
TEM
, and
bla
OXA.
Plasmid DNA profiles were determined to assess significance between resistance to antimicrobial agents and plasmid number. It was found that among non-hematologic malignancy isolates, the highest rate of resistance was 87.9% to imipenem, with lowest rate being 2% to ampicillin. However, in hematologic malignancy isolates, the highest microbial resistance was 92.9% to ampicillin with the lowest rate of resistance at 28.6% to imipenem. Among collected isolates, 45% were ESBL-producers with 50% occurrence in hematologic malignancy individuals that were ESBL-producers. Within ESBL-producing isolates from hematologic malignancy individuals
, bla
SHV
was detected in 100%,
bla
CTX
-M
in 85.7%, and
bla
TEM
and
bla
OXA-1
at 57.1% and 27.1%, respectively. In addition,
bla
SHV,
bla
CTX-M
, and
bla
OXA
were found in all non-hematological malignancy individuals with
bla
TEM
detected in 55.5% of samples. Our findings indicate that ESBLs expressing
bla
SHV
and
bla
CTX-M
genes are significantly prevalent in
K. pneumoniae
isolates from hematologic malignancy individuals. Plasmid analysis indicated plasmids in isolates collected from hematological malignancy individuals. Furthermore, there was a correlation between resistance to antimicrobial agents and plasmids within two groups analyzed. This study indicates an increase in incidence of
K. pneumoniae
infections displaying ESBL phenotypes in Jordan.</description><subject>Ampicillin</subject><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>beta-Lactamases - genetics</subject><subject>Extended-spectrum β-lactamases</subject><subject>Hematological malignancy</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Imipenem</subject><subject>Jordan</subject><subject>Jordan - epidemiology</subject><subject>Klebsiella pneumoniae</subject><subject>Klebsiella pneumoniae - genetics</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Multidrug resistance</subject><subject>Plasmid profile</subject><subject>Prevalence</subject><subject>Research Article</subject><issn>2210-6014</issn><issn>2210-6006</issn><issn>2210-6014</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>EIF</sourceid><sourceid>DOA</sourceid><recordid>eNp9kU9u1TAQxiMEolXpBVigXCAwduw4XiFUlfbBQyD-rC3HnjxcJXZkOxVwLA7CmTANVO2GzcxoZr7fSPNV1VMCzwmAeJEYI1I0QNsGAGTX0AfVMaUEmg4Ie3inPqpOU3IDMCYlZ9A-ro5aAZKXcFz9-BDxWk_oDdZhrM-_ZfQWbfNpQZPjOte_fjZ7bbKedcJUO1-_W6fsbFwPzUdMLmXtc_12wiE5nCZdLx7XOXinsd6lMOm8qd6EaHXp-voypMVlPaUn1aOxJDz9m0-qL6_PP59dNvv3F7uzV_vGcNLmEo20jFhkZhCjBeg46JbLcRDSCtpT4NRqgZSP0lDOe8sZ02zsjByMpLY9qXYb1wZ9pZboZh2_q6CdummEeFA6ZmcmVH1nBt72YMZWMCv5wDpDsTcFiFIKUVgvN9ayDjNagz5HPd2D3p9491UdwrUiQAUF2hcC3QgmhpQijrdiAuqPs2pzVhVn1Y2zihbRs7tnbyX_fCwL7baQysgfMKqrsEZf3vo_7G_N2LKq</recordid><startdate>20230601</startdate><enddate>20230601</enddate><creator>Al-Sheboul, Suhaila A.</creator><creator>Al-Madi, Ghina S.</creator><creator>Brown, Brent</creator><creator>Hayajneh, Wail A.</creator><general>Springer Netherlands</general><general>Springer</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-5238-6943</orcidid><orcidid>https://orcid.org/0000-0001-9001-3232</orcidid><orcidid>https://orcid.org/0000-0003-1816-9018</orcidid></search><sort><creationdate>20230601</creationdate><title>Prevalence of Extended-Spectrum β-Lactamases in Multidrug-Resistant Klebsiella pneumoniae Isolates in Jordanian Hospitals</title><author>Al-Sheboul, Suhaila A. ; Al-Madi, Ghina S. ; Brown, Brent ; Hayajneh, Wail A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c513t-c5c9d41de4cb7fd00650a359fb79d7282052da7e25f9c2558d544a4f6c9bc92d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Ampicillin</topic><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>beta-Lactamases - genetics</topic><topic>Extended-spectrum β-lactamases</topic><topic>Hematological malignancy</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Imipenem</topic><topic>Jordan</topic><topic>Jordan - epidemiology</topic><topic>Klebsiella pneumoniae</topic><topic>Klebsiella pneumoniae - genetics</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Multidrug resistance</topic><topic>Plasmid profile</topic><topic>Prevalence</topic><topic>Research Article</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Al-Sheboul, Suhaila A.</creatorcontrib><creatorcontrib>Al-Madi, Ghina S.</creatorcontrib><creatorcontrib>Brown, Brent</creatorcontrib><creatorcontrib>Hayajneh, Wail A.</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Journal of Epidemiology and Global Health</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Al-Sheboul, Suhaila A.</au><au>Al-Madi, Ghina S.</au><au>Brown, Brent</au><au>Hayajneh, Wail A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prevalence of Extended-Spectrum β-Lactamases in Multidrug-Resistant Klebsiella pneumoniae Isolates in Jordanian Hospitals</atitle><jtitle>Journal of Epidemiology and Global Health</jtitle><stitle>J Epidemiol Glob Health</stitle><addtitle>J Epidemiol Glob Health</addtitle><date>2023-06-01</date><risdate>2023</risdate><volume>13</volume><issue>2</issue><spage>180</spage><epage>190</epage><pages>180-190</pages><issn>2210-6014</issn><issn>2210-6006</issn><eissn>2210-6014</eissn><abstract>The increase in the prevalence of infections caused by certain bacteria, such as
Klebsiella pneumonia
(
K. pneumoniae
), is a global health concern. Bacterial production of an enzyme called extended-spectrum beta-lactamase (ESBL) can generate resistance to antimicrobial therapeutics. Therefore, between 2012 and 2013, we investigated
K. pneumoniae
that produce ESBLs with the prevalence of individual genes including
bla
SHV
,
bla
CTX-M
,
bla
TEM
, and
bla
OXA
isolated from clinical samples. A total of 99 variable diagnostic samples including blood from hematological malignancies (
n
= 14) or other clinical sources including sputum, pus, urine, and wound (
n
= 85) were analyzed. All samples' bacterial type was confirmed and their susceptibility to antimicrobial agents was established. Polymerase chain reaction (PCR) amplification was carried out to ascertain presence of specific genes that included
bla
SHV
,
bla
CTX-M
,
bla
TEM
, and
bla
OXA.
Plasmid DNA profiles were determined to assess significance between resistance to antimicrobial agents and plasmid number. It was found that among non-hematologic malignancy isolates, the highest rate of resistance was 87.9% to imipenem, with lowest rate being 2% to ampicillin. However, in hematologic malignancy isolates, the highest microbial resistance was 92.9% to ampicillin with the lowest rate of resistance at 28.6% to imipenem. Among collected isolates, 45% were ESBL-producers with 50% occurrence in hematologic malignancy individuals that were ESBL-producers. Within ESBL-producing isolates from hematologic malignancy individuals
, bla
SHV
was detected in 100%,
bla
CTX
-M
in 85.7%, and
bla
TEM
and
bla
OXA-1
at 57.1% and 27.1%, respectively. In addition,
bla
SHV,
bla
CTX-M
, and
bla
OXA
were found in all non-hematological malignancy individuals with
bla
TEM
detected in 55.5% of samples. Our findings indicate that ESBLs expressing
bla
SHV
and
bla
CTX-M
genes are significantly prevalent in
K. pneumoniae
isolates from hematologic malignancy individuals. Plasmid analysis indicated plasmids in isolates collected from hematological malignancy individuals. Furthermore, there was a correlation between resistance to antimicrobial agents and plasmids within two groups analyzed. This study indicates an increase in incidence of
K. pneumoniae
infections displaying ESBL phenotypes in Jordan.</abstract><cop>Dordrecht</cop><pub>Springer Netherlands</pub><pmid>37095370</pmid><doi>10.1007/s44197-023-00096-2</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0001-5238-6943</orcidid><orcidid>https://orcid.org/0000-0001-9001-3232</orcidid><orcidid>https://orcid.org/0000-0003-1816-9018</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2210-6014 |
ispartof | Journal of Epidemiology and Global Health, 2023-06, Vol.13 (2), p.180-190 |
issn | 2210-6014 2210-6006 2210-6014 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10272028 |
source | MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central Open Access; Springer Nature OA Free Journals; PubMed Central; SpringerLink Journals - AutoHoldings |
subjects | Ampicillin Anti-Bacterial Agents - pharmacology Anti-Bacterial Agents - therapeutic use beta-Lactamases - genetics Extended-spectrum β-lactamases Hematological malignancy Hospitals Humans Imipenem Jordan Jordan - epidemiology Klebsiella pneumoniae Klebsiella pneumoniae - genetics Medicine Medicine & Public Health Multidrug resistance Plasmid profile Prevalence Research Article |
title | Prevalence of Extended-Spectrum β-Lactamases in Multidrug-Resistant Klebsiella pneumoniae Isolates in Jordanian Hospitals |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T01%3A58%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prevalence%20of%20Extended-Spectrum%20%CE%B2-Lactamases%20in%20Multidrug-Resistant%20Klebsiella%20pneumoniae%20Isolates%20in%20Jordanian%20Hospitals&rft.jtitle=Journal%20of%20Epidemiology%20and%20Global%20Health&rft.au=Al-Sheboul,%20Suhaila%20A.&rft.date=2023-06-01&rft.volume=13&rft.issue=2&rft.spage=180&rft.epage=190&rft.pages=180-190&rft.issn=2210-6014&rft.eissn=2210-6014&rft_id=info:doi/10.1007/s44197-023-00096-2&rft_dat=%3Cpubmed_doaj_%3E37095370%3C/pubmed_doaj_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/37095370&rft_doaj_id=oai_doaj_org_article_86cb5380cf374d95b46c2e8c44ae9977&rfr_iscdi=true |